By standing up for his personal values, Merck & Co. Inc. CEO Kenneth Frazier may have put the pharma industry – and high drug prices – back in President Trump's sightline.
Pharma industry leaders have been hesitant of speaking out against some of the president's more controversial initiatives and comments, but...





